Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
PHASE3
Follicular lymphoma (FL) is the second most common B-cell cancer and the mo...
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
PHASE1
This is a multicenter, open-label, dose-finding study of venetoclax adminis...
A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients
N/A
This is a prospective , open, multicenter, randomized phase Ⅲ study. The in...
Status
Unknown
Location
Tumor center, Sun Yat-sen University
Start Date
2008-01
Trial ID
NCT01793844
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
PHASE3
This open-label, randomized, parallel group study will evaluate the efficac...